EUCTR2005-003717-33-IT进行中（未招募）1 期
Open-Label, limited access protocol of Posaconazole in invasive fungal infections.
SCHERING-PLOUGH0 个研究点开始时间: 2007年1月19日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
已完成
3 期
Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P02095)MycosesNCT00034632Merck Sharp & Dohme LLC
已完成
3 期
Open Label Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P00041)MycosesNCT00034658Merck Sharp & Dohme LLC336
进行中（未招募）
1 期
Protocol for therapeutic use of Posaconazolo out of clinical trials in patients with invasive resistant micosis and/or in tolerant patients. - NDEUCTR2006-004968-32-ITOSPEDALE S. RAFFAELE100
已完成
3 期
Posaconazole to Treat Invasive Fungal InfectionsGranulomatous Disease, ChronicJob's SyndromeInfectionNCT00033982National Institute of Allergy and Infectious Diseases (NIAID)50
进行中（未招募）
1 期
Open-Label Access Protocol of Denosumab for Subjects with Advanced CancerBone Metastases in Subjects with Advanced Breast Cancer and Bone Metastases in Men with Hormone-Refractory Prostate CancerMedDRA version: 14.1 Level: LLT Classification code 10027475 Term: Metastatic breast cancer System Organ Class: 100000004864MedDRA version: 14.1 Level: LLT Classification code 10005993 Term: Bone metastases System Organ Class: 100000004864MedDRA version: 14.1 Level: LLT Classification code 10062904 Term: Hormone-refractory prostate cancer System Organ Class: 100000004864EUCTR2011-002114-36-BEAmgen Inc129